A Study to Compare Efficacy, Pharmacokinetics, Safety and Immunogenicity of MB04 [proposed Etanercept Biosimilar] to Enbrel® [EU-sourced] in Rheumatoid Arthritis
Clinical trial NCT06596772 · RECRUITING
Trial details
- NCT number
- NCT06596772
- Sponsor
- mAbxience Research S.L.
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-10-03
- Primary completion
- 2025-10-01
- Enrollment
- 458
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.